Pharmaceutical products supplier today: Reliable commercial drug sourcing and supply for clinical research, with a truly global approach. ClientPharma is perfectly equipped to ensure fast, accurate and reliable pharmaceutical supply. With unparalleled service and unmatched access, ClientPharma sources and supplies commercial drug product for global clinical trials. From provision of clinical research samples, to bulk supplies for your pivotal trials, we have the network and know-how to provide strategic sourcing solutions at every stage of clinical research. Find extra info on pharmaceutical risk mitigation and competitiveness.
Our highly experienced team is ready to hear from you. Please reach out to us with any questions or clinical supply requirements. We look forward to working with you and helping to make your clinical program a success! We Think of Everything, So You Don’t Have To: ClientPharma’s extensive experience and expertise means we provide both comprehensive and pragmatic guidance; delivering on point and on time – no matter how technically challenging.
Our open and collaborative approach is tailored to you and your patients’ needs for every study. With dedicated points-of-contact and direct access to senior management, you are always in connection with us. Through regular business review meetings and custom KPIs, we never lose sight of what’s important to you, your team and your program. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch.
Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. See extra details at https://www.clientpharma.com/.
Under this partnership, clients will now enjoy an expanded reach by leveraging ClientPharma’s global sourcing, procurement and distribution logistics while also having the ability to utilize the RxStudy CardTM, TrialCard’s virtual inventory supply solution that has been augmented to place physical inventories of medication at sites for protocol designs that require immediate dosing. This will cut supply costs by 50% and reduce clinical supply teams’ efforts by 80%. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.